• Immunogenicity Assessment

    • Therapeutic In Silico Services
      • ISPRIâ„¢ Website
      • ISPRI Downselectâ„¢
      • ISPRI Quantifyâ„¢
      • ISPRI Analyzeâ„¢
      • ISPRI Evaluateâ„¢
      • ISPRI-HCPâ„¢
      • ISPRI Designâ„¢
      • PANDA® Screening
    • Vaccine In Silico Services
      • iVAXâ„¢
      • EpiCCâ„¢
      • Ancer®
      • PreVAXâ„¢
    • Lab Services
      • All In Vitro Assays
      • Generic Peptide PANDA® Assays
    • Consulting Services
      • Trusted Expert Advice (TEA)
      • IRA / ISI Regulatory Writing Support
    • Why Immunogenicity Risk Assessment?
    • Why EpiVax?
  • About Us
    • Company History
    • Leadership
    • Careers
  • Press
    • News
    • Events
    • Publications
    • Blog
  • Contact Us
Epitope-Driven TB Vaccine Development: A streamlined approach using immunoinformatics, ELISpot assays, and HLA transgenic mice

Epitope-Driven TB Vaccine Development: A streamlined approach using immunoinformatics, ELISpot assays, and HLA transgenic mice

by Adam | Oct 22, 2016

Current Molecular Medicine, Curr Mol Med. 2007 Jun;7(4):351-68.
Diversity of Francisella tularensis Schu4 antigens recognized by T lymphocytes after natural infections in humans: Identification of candidate epitopes for inclusion in a rationally designed tularemia vaccine

Diversity of Francisella tularensis Schu4 antigens recognized by T lymphocytes after natural infections in humans: Identification of candidate epitopes for inclusion in a rationally designed tularemia vaccine

by Adam | Oct 22, 2016

Vaccine. 2007 Apr 20;25(16):3179-91.
Analysis of ChimeriVax Japanese Encephalitis (JE) Virus envelope for T-cell epitopes and comparison to circulating strain sequences

Analysis of ChimeriVax Japanese Encephalitis (JE) Virus envelope for T-cell epitopes and comparison to circulating strain sequences

by Adam | Oct 22, 2016

Identification of genome-derived vaccine candidates conserved between human and mouse-adapted strains of H. pylori

Identification of genome-derived vaccine candidates conserved between human and mouse-adapted strains of H. pylori

by Adam | Oct 22, 2016

Hum Vaccin. 2008 May-Jun;4(3):219-23. Epub 2010 May 8.
In Silico-Accelerated Identification of Conserved and Immunogenic Variola/Vaccinia T-Cell Epitopes

In Silico-Accelerated Identification of Conserved and Immunogenic Variola/Vaccinia T-Cell Epitopes

by Adam | Oct 22, 2016

« Older Entries
Next Entries »

Recent Posts

  • EpiVax Announces Laboratory Expansion and Streamlined, NAM-Centric In Vitro Services    
  • Replacing Animal Models with Human-Relevant New Approach Methodologies (NAMs) for Immunogenicity in Clinic
  • EpiVax Enters its Next Chapter with SV Health Investors
  • Immunogenicity Risk Assessment Outputs to Drive a Streamlined, Risk-Based Preclinical and Clinical Strategy
  • Immunogenicity Risk Assessment Outputs to Drive a Streamlined, Risk-Based Preclinical and Clinical Strategy

Recent Comments

No comments to show.

Explore

Therapeutic In Silico Services

Vaccine In Silico Services

Lab Services

Consulting

LinkedIn

About Us

Careers

News

Events

Publications

Contact Us

This website uses cookies and similar technologies to collect information about your website experience for advertising, analytics, and other purposes as described in our Privacy Policy.